menu
    • menu
    [{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2013","type":"Inapplicable","leadProduct":"Seasonal Influenza Virus Vaccine","moa":"Influenza virus hemagglutinin\/neuraminidase","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2015","type":"Inapplicable","leadProduct":"Seasonal Influenza Virus Vaccine","moa":"Influenza virus hemagglutinin\/neuraminidase","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2010","type":"Inapplicable","leadProduct":"Seasonal Influenza Virus Vaccine","moa":"Influenza virus hemagglutinin\/neuraminidase","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2018","type":"Inapplicable","leadProduct":"4-fluart Inactivated Influenza Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"FAB-6011","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"FAB-6011","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2011","type":"Inapplicable","leadProduct":"Fluval AB Influenza Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Gel","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2012","type":"Inapplicable","leadProduct":"Fluval AB VAccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Suspension","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"},{"orgOrder":0,"company":"Fluart Innovative Vaccines","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"HUNGARY","productType":"Vaccine","year":"2011","type":"Inapplicable","leadProduct":"Fluval P Monovalent Influenza Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Fluart Innovative Vaccines","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Gel","sponsorNew":"Fluart Innovative Vaccines \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Fluart Innovative Vaccines \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by Fluart Innovative Vaccines

    Menu

    Fluart Innovative Vaccines

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 4-fluart Inactivated Influenza Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety of 4Fluart ID Suspension for Injection in Adult Subjects

                            Details : 4-fluart Inactivated Influenza Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            February 28, 2018

                            Lead Product(s) : 4-fluart Inactivated Influenza Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Seasonal Influenza Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

                            Details : Seasonal Influenza Virus Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            March 13, 2015

                            Lead Product(s) : Seasonal Influenza Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Seasonal Influenza Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection

                            Details : Seasonal Influenza Virus Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            May 29, 2013

                            Lead Product(s) : Seasonal Influenza Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fluval AB VAccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the...

                            Details : Fluval AB VAccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            July 25, 2012

                            Lead Product(s) : Fluval AB VAccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : FAB-6011

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elde...

                            Details : FAB-6011 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            October 25, 2011

                            Lead Product(s) : FAB-6011

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : FAB-6011

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elde...

                            Details : FAB-6011 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 03, 2011

                            Lead Product(s) : FAB-6011

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fluval P Monovalent Influenza Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

                            Details : Fluval P Monovalent Influenza Vaccine is a Vaccine drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            August 02, 2011

                            Lead Product(s) : Fluval P Monovalent Influenza Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fluval AB Influenza Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

                            Details : Fluval AB Influenza Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            July 27, 2011

                            Lead Product(s) : Fluval AB Influenza Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed

                            Fluart Innovative Vaccines

                            Hungary arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Seasonal Influenza Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

                            Details : Seasonal Influenza Virus Vaccine is a Vaccine drug candidate, which is currently being evaluated in clinical studies for the treatment of Influenza, Human.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            April 08, 2010

                            Lead Product(s) : Seasonal Influenza Virus Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth